Vertex Pharmaceuticals

Vertex Pharmaceuticals in Fortune Rankings

Vertex Pharmaceuticals, a biotechnology company, develops and commercializes therapies for serious chronic conditions such as cystic fibrosis, which damages the lungs, digestive system, and other organs. Vertex also developed Casgevy, one of two gene therapies approved for the treatment of sickle cell anemia, a rare and painful blood disorder. Casgevy is also the first FDA-approved therapy that utilizes CRISPR/Cas9 genome editing technology.
  • Updated:6/3/26
  • Country/Territory:U.S.
  • Headquarters:Boston
  • Industry:Pharmaceuticals
  • CEO:Reshma Kewalramani
  • Website:https://www.vrtx.com
  • Ticker:VRTX
  • Company type:Public
  • Revenues ($M):$12,001
  • Profits ($M):$3,953
  • Market value ($M):$113,436
  • Number of employees:6,400

Market value as of March 31, 2026.

Vertex Pharmaceuticals stock chart

Vertex Pharmaceuticals in Fortune Rankings


View the Full List